Mink Therapeutics Correlations

INKT Stock

USD 0.70 0.01 1.45%

The current 90-days correlation between Mink Therapeutics and Affimed NV is 0.26 (i.e., Modest diversification). The correlation of Mink Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Mink Therapeutics Correlation With Market

Average diversification

The correlation between Mink Therapeutics and DJI is 0.19 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Mink Therapeutics and DJI in the same portfolio, assuming nothing else is changed.

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Mink Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in industry.

For more information on how to buy Mink Stock please use our How to Invest in Mink Therapeutics guide.

Moving together with Mink Stock

0.8	VRAX	Virax Biolabs Group	Pair Corr
0.78	VRPX	Virpax Pharmaceuticals	Pair Corr
0.64	XFOR	X4 Pharmaceuticals	Pair Corr
0.62	KPRX	Kiora Pharmaceuticals	Pair Corr
0.64	KURA	Kura Oncology	Pair Corr
0.61	REVB	Revelation Biosciences	Pair Corr
0.71	STOK	Stoke Therapeutics	Pair Corr
0.79	BDRX	Biodexa Pharmaceticals	Pair Corr

Moving against Mink Stock

0.74	VRDN	Viridian Therapeutics	Pair Corr
0.7	EWTX	Edgewise Therapeutics	Pair Corr
0.67	BMEA	Biomea Fusion	Pair Corr
0.64	NTRB	Nutriband	Pair Corr
0.58	PRAX	Praxis Precision Med	Pair Corr
0.53	ALVO	Alvotech	Pair Corr
0.51	AKRO	Akero Therapeutics	Pair Corr
0.49	AMLX	Amylyx Pharmaceuticals	Pair Corr
0.82	HD	Home Depot	Pair Corr
0.8	IBM	International Business Fiscal Year End 22nd of January 2025	Pair Corr
0.76	PTAIF	PT Astra International	Pair Corr
0.74	SSNLF	Samsung Electronics	Pair Corr
0.73	CAT	Caterpillar Fiscal Year End 3rd of February 2025	Pair Corr
0.71	MCD	McDonalds Fiscal Year End 3rd of February 2025	Pair Corr
0.68	AA	Alcoa Corp Fiscal Year End 15th of January 2025	Pair Corr
0.67	T	ATT Inc Aggressive Push	Pair Corr

Related Correlations Analysis

	AFMD	IMGN	ADAP	SGMO	DAWN	ABOS	XFOR	INZY	VECT	TERN
AFMD		-0.7	0.72	-0.15	0.05	0.36	0.67	0.38	-0.7	0.36	AFMD
IMGN	-0.7		-0.89	0.58	0.4	-0.01	-0.74	-0.5	0.89	-0.34	IMGN
ADAP	0.72	-0.89		-0.67	-0.25	-0.07	0.84	0.72	-0.89	0.56	ADAP
SGMO	-0.15	0.58	-0.67		0.57	0.56	-0.53	-0.8	0.65	-0.57	SGMO
DAWN	0.05	0.4	-0.25	0.57		0.63	-0.04	-0.15	0.42	-0.11	DAWN
ABOS	0.36	-0.01	-0.07	0.56	0.63		0.08	-0.14	0.15	-0.26	ABOS
XFOR	0.67	-0.74	0.84	-0.53	-0.04	0.08		0.71	-0.82	0.7	XFOR
INZY	0.38	-0.5	0.72	-0.8	-0.15	-0.14	0.71		-0.6	0.7	INZY
VECT	-0.7	0.89	-0.89	0.65	0.42	0.15	-0.82	-0.6		-0.59	VECT
TERN	0.36	-0.34	0.56	-0.57	-0.11	-0.26	0.7	0.7	-0.59		TERN
	AFMD	IMGN	ADAP	SGMO	DAWN	ABOS	XFOR	INZY	VECT	TERN

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

VECT	+ 0.89	IMGN
XFOR	+ 0.84	ADAP
ADAP	+ 0.72	AFMD
INZY	+ 0.72	ADAP
INZY	+ 0.71	XFOR
TERN	+ 0.7	XFOR

High negative correlations

VECT	- 0.89	ADAP
ADAP	- 0.89	IMGN
VECT	- 0.82	XFOR
INZY	- 0.8	SGMO
XFOR	- 0.74	IMGN
VECT	- 0.7	AFMD

Risk-Adjusted Indicators

There is a big difference between Mink Stock performing well and Mink Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Mink Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
AFMD	2.49	(0.71)	0.00	(0.43)	0.00	0.00	6.39	(6.82)	21.12
IMGN	5.45	2.94	1.08	3.91	1.44	(6.91)	8.32	(4.16)	141.41
ADAP	3.30	(0.73)	0.00	(0.40)	0.00	0.00	9.59	(6.00)	35.64
SGMO	6.38	1.35	0.30	0.40	4.54	(8.81)	24.14	(7.53)	50.57
DAWN	2.11	(0.09)	(0.03)	(0.01)	2.79	(1.99)	3.84	(3.69)	11.44
ABOS	3.50	(0.43)	0.00	(0.05)	0.00	0.00	7.52	(6.67)	28.07
XFOR	4.83	(0.76)	0.00	(0.42)	0.00	0.00	6.45	(10.61)	62.35
INZY	2.67	(1.00)	0.00	(0.41)	0.00	0.00	5.68	(7.92)	16.62
VECT	2.63	1.13	0.56	(5.36)	0.88	(3.64)	5.61	(3.08)	39.30
TERN	3.39	(0.43)	0.00	(0.29)	0.00	0.00	5.68	(5.96)	34.09

Mink Therapeutics Corporate Management

Kimberly Ha	Head Relations	Profile
Joy Zhou	Vice CMC	Profile
Marcus Dijk	Chief Officer	Profile
Heather Boussios	General Officer	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC